BIMINI Biotech is the proud winner of the LSW Venture Challenge. Over the course of three months, we have been working hard on the business case of our breakthrough innovation – a novel cure for triple negative breast cancer. Now, we aim to accelerate the development of our lead compound to bring it to the clinic. We will use the award of €25.000 to initiate key-experiments to further elucidate our mechanism of action.
We would like to thank the LSW Venture challenge team Math Kohnen, Chrétien Herben and Thom Frielink, as well as the other teams.